0001171843-18-000685 Sample Contracts

HARVARD BIOSCIENCE, INC. UNAUDITED PRO FORMA FINANCIAL INFORMATION

Harvard Bioscience Inc • January 26th, 2018 • Laboratory analytical instruments

• Company
  Harvard Bioscience Inc
• Filed
  January 26th, 2018
• Industry
  Laboratory analytical instruments

Harvard Bioscience, Inc. (the “Company”) has entered into a Purchase Agreement, dated January 22, 2018 (the “Purchase Agreement”), pursuant to which the Company sold substantially all of the assets of its wholly-owned subsidiary, Denville Scientific, Inc. (“Denville”) to Thomas Scientific, LLC (“Thomas Scientific”) for approximately $20 million, which includes a $3 million earn-out provision. At the completion of the sale, the Company received $17 million in cash from Thomas Scientific, including cash held in escrow.

PURCHASE AGREEMENT by and among Thomas Scientific, LLC, Denville Scientific, Inc., and Harvard Bioscience, Inc. Dated as of January 22, 2018

Purchase Agreement • January 26th, 2018 • Harvard Bioscience Inc • Laboratory analytical instruments • New York

• Contract Type
  Purchase Agreement
• Filed
  January 26th, 2018
• Company
  Harvard Bioscience Inc
• Industry
  Laboratory analytical instruments
• Jurisdiction
  New York

This Purchase Agreement (“Agreement”) is dated as of January 22, 2018, by and among Thomas Scientific, LLC, a Delaware limited liability company (“Buyer”), Denville Scientific, Inc., a Delaware corporation (“Denville” or “Seller”), and Harvard Bioscience, Inc., a Delaware corporation (“Stockholder”), in its individual capacity and in its capacity as representative of Seller and Stockholder in accordance with Section 2.12 (in such capacity, “Seller’s Representative”).

AGREEMENT AND PLAN OF MERGER by and among HARVARD BIOSCIENCE, INC. and PLYMOUTH SUB, INC. and DATA SCIENCES INTERNATIONAL, INC. and THE STOCKHOLDER REPRESENTATIVE Dated as of January 22, 2018 AGREEMENT AND PLAN OF MERGER

Agreement and Plan of Merger • January 26th, 2018 • Harvard Bioscience Inc • Laboratory analytical instruments • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  January 26th, 2018
• Company
  Harvard Bioscience Inc
• Industry
  Laboratory analytical instruments
• Jurisdiction
  Delaware

This AGREEMENT AND PLAN OF MERGER (this “Agreement”), is made and entered into as of January 22, 2018, by and among Harvard Bioscience, Inc., a Delaware corporation (“Parent”), Plymouth Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Data Sciences International, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Section 11.01 herein, Plymouth Stockholder Rep, LLC (the “Stockholder Representative”).